Advancing Precision Oncology

Cairina is redefining personalized cancer treatment with our groundbreaking software platform. Built on two decades of research in tumor fluid dynamics, our technology enhances surgical planning, optimizes radiotherapy and drug delivery, and provides early insights into treatment response—all without requiring additional imaging or changes to standard clinical workflows.

Improving Personalized Cancer Care

Our proprietary 3D visualization platform delivers real-time, tumor-specific insights, empowering oncologists, radiologists, and surgeons to make faster, more precise treatment decisions. Seamlessly integrating with existing medical imaging systems, Cairina elevates precision oncology, making cutting-edge cancer care more efficient, accessible, and impactful.

Growing Market Opportunity

The oncology software market is surging, projected to hit $7.5 billion by 2030, fueled by the accelerating demand for precision medicine and advanced treatment planning. With cancer cases rising worldwide, the need for cutting-edge technologies that sharpen surgical accuracy, optimize radiotherapy, and revolutionize treatment monitoring has never been more critical.

Scalable and Protected Technology

Cairina’s patent-protected software delivers real-time, high-precision insights through advanced physics-based modeling and fluid dynamics visualization—all without additional imaging or equipment. Seamlessly integrating into hospital systems, Cairina optimizes surgical precision, radiotherapy, and treatment monitoring, equipping healthcare providers with the tools to improve patient outcomes and streamline oncology workflows.

Investment Opportunities

Cairina is forging strategic partnerships with top cancer centers, research institutions, and medical device companies to validate and deploy our cutting-edge technology in clinical settings. Our revenue model is built on licensing agreements, ensuring sustainable growth and widespread adoption without requiring additional imaging or workflow disruptions. With a clear commercialization roadmap, we are positioned for a high-value acquisition by a leading medical imaging, oncology, or healthcare technology company. Now is the time to invest in the future of precision cancer treatment—partner with us to bring this transformative technology to the patients who need it most.

Current Partners

Groundbreaking Technology

Our proprietary localized convolutional function regression (LCFR) method revolutionizes dynamic MRI analysis, providing detailed, non-invasive measurements of interstitial fluid dynamics within tumors. This technology enhances treatment planning, improves therapeutic targeting, and supports personalized medicine approaches.

Clinically Validated Solutions

Our methodologies have been rigorously validated in vitro, in vivo, and through clinical trials, demonstrating accuracy and efficacy across diverse tumor types. We offer robust, scalable solutions that integrate seamlessly into existing oncology workflows.

Commitment to Innovation

Cairina is driven by a mission to advance cancer diagnostics and treatment. Our research-backed approach and continuous development ensure we stay at the cutting edge of biomedical technology.

Join Us in Transforming Cancer Care

By partnering with Cairina, you’ll be at the forefront of innovation, contributing to a future where personalized, data-driven oncology is the standard of care. Together, we can revolutionize cancer diagnostics and improve patient outcomes worldwide. For partnership inquiries, please email us at: [email protected]